April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
April 22, 2021
Taejeong Song, PhD, a postdoctoral fellow in the UC College of Medicine, says a regulatory protein found in skeletal muscle fiber may play an important role in the body’s fight or flight response when encountering dangerous situations.
November 3, 2021
UC is part of a multi-institutional grant of nearly $2 million from the Centers for Disease Control and Prevention to improve the design, function and safety of personal protective equipment. UC researchers will work with teams from Iowa State University and the University of California-Davis on this four-year grant. One of the goals is to develop self-decontaminating PPE featuring high-protection efficiency
September 28, 2021
The University of Cincinnati College of Medicine is opening what it calls a “heart bank” to collect tissue samples that can be used by researchers. Those samples will be stored in a biorepository to provide a potentially valuable resource to help researchers find answers to scientific questions.
October 7, 2022
A University of Cincinnati Venture Lab-backed startup is developing a breast cancer treatment that may be more effective with fewer side effects thanks to RNA nanotechnology that is similar to what was used to produce COVID-19 vaccines.
July 28, 2023
No one wants to hear a diagnosis of cancer, but if anything is worse it would be a diagnosis that comes too late. Jiajie Diao, associate professor in the University of Cincinnati College of Medicine, has invented a method for detecting early-stage cancers that could help his colleagues at UC and worldwide save many lives.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
May 20, 2020
Joan Garrett, PhD, assistant professor of pharmaceutical sciences at the University of Cincinnati's James L. Winkle College of Pharmacy, hopes to learn more about HER3 and its role in breast cancer development.